Retinoblastoma in the United States: A 40-Year Incidence and Survival Analysis
- 1 May 2018
- journal article
- research article
- Published by SLACK, Inc. in Journal of Pediatric Ophthalmology & Strabismus
- Vol. 55 (3), 182-188
- https://doi.org/10.3928/01913913-20171116-03
Abstract
Purpose: To determine the incidence of retinoblastoma in the United States from 1973 to 2012 (40 years) and characterize the 5-year overall survival rate of the included patients. Methods: Cases of retinoblastoma were derived from the Surveillance, Epidemiology, and End Results (SEER) Program (National Cancer Institute, Rockville, MD). Incidence rates were calculated using U.S. Census Bureau data as the standard population, and trends over time were determined using the chi-square test. Hazard ratios with a 95% confidence interval (CI) were estimated for variables associated with mortality using Cox regression models. Survival rates were calculated using the Kaplan–Meier method and compared among different clinical and demographic categories. Results: A total of 879 cases of retinoblastoma were derived from the SEER databases. The annual incidence rates of retinoblastoma for a period of 40 years were 12.14 (95% CI: 11.32 to 12.96) cases per 1 million children 4 years or younger and 0.49 (95% CI: 0.36 to 0.65) cases per 1 million children between the ages of 5 and 9 years. There was no significant trend for children 4 years or younger ( P = .6324) or between the ages of 5 and 9 years ( P = .7695). The 5-year overall survival rates were 97.6%, 92.7%, 91.1%, and 96.4% for children diagnosed at the first, second, third, and after the third year of life, respectively ( P = .0136). The 5-year overall survival rates were 92.5% for bilateral and 96.3% for unilateral cases ( P = .0116). The 5-year overall survival rates were 90.8%, 92.5%, 97.6%, 97.3% for increasing time intervals (1973 to 1979, 1980 to 1989, 1990 to 1999, and 2000 to 2012, respectively; P = .0017). Conclusions: The incidence rate of retinoblastoma in the United States has remained stable for the past 40 years. Survival rate analysis indicates a significant effect of laterality of tumor, age at diagnosis, and decade of diagnosis. [ J Pediatr Ophthalmol Strabismus . 2018;55(3):182–188.]This publication has 31 references indexed in Scilit:
- Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapyCurrent Opinion in Opthalmology, 2010
- Familial retinoblastoma in developing countriesPediatric Blood & Cancer, 2009
- Survival with retinoblastoma in the USA: 1975-2004British Journal of Ophthalmology, 2008
- Incidence of retinoblastoma in the USA: 1975-2004British Journal of Ophthalmology, 2008
- Retinoblastoma in Turkey: survival and clinical characteristics 1981–2004Pediatrics International, 2006
- Retinoblastoma in Taiwan: Survival Rate and Prognostic FactorsJapanese Journal of Ophthalmology, 2006
- Incidence of retinoblastoma from 1958 to 1998 in Northern Europe*1Advantages of birth cohort analysisOphthalmology, 2004
- A 12-year epidemiological review of retinoblastoma in Omani childrenOphthalmic Epidemiology, 2004
- Thirty years of retinoblastoma (1960–89): changing patterns of incidencePaediatric and Perinatal Epidemiology, 1994
- Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival.British Journal of Ophthalmology, 1988